INmune Bio Inc.
June 30, 2025 - by Joey Ramson
$INMB is getting crushed today after its experimental Alzheimer’s drug XPro failed to improve cognitive functions in patients with early stages of the disease in a mid-stage study. On top of that as mentioned on Friday, the company announced a direct stock offering. Shares are currently at an all-time low.
